The digital health sector is entering a recalibration phase, driven by the need for demonstrable returns on investment. Key areas of focus include AI workflows, chronic disease management, and measurable healthcare outcomes, which are expected to reshape the industry landscape in the near future.
According to Holland & Knight's Healthcare Trend Report, the focus has shifted from rapid growth to a more disciplined approach emphasizing capital efficiency. This change impacts decision-makers in health systems, as they now face heightened scrutiny in vendor evaluations and contract negotiations. The report indicates that the criteria for selecting digital health partners are becoming increasingly stringent across various dimensions.
AI workflows are transitioning from pilot programs to permanent procurement decisions. Health systems that tested these technologies in previous years are now asking more rigorous questions about performance and integration capabilities. Contract terms are evolving to include performance-linked metrics and tighter data governance, reflecting a broader market demand for accountability.
Chronic disease management is highlighted as a critical area, where health systems are keenly aware of long-term costs. Technologies for remote monitoring and AI-assisted care are attracting both commercial interest and regulatory scrutiny. The report advises procurement teams to conduct thorough evaluations that include legal compliance alongside clinical and financial assessments to mitigate risks effectively.
This recalibration phase indicates a significant shift in how digital health contracts are structured, requiring collaboration among legal, IT, clinical, and financial teams. As regulations around AI and data privacy evolve, health systems must adapt their contracting strategies to address emerging risks and ensure sustainable partnerships.